US FDA panel gives a guarded "yes" to OraSure's 20-minute home HIV test
This article was originally published in Clinica
Executive Summary
After listening to 10 hours of testimony from AIDs activists, private citizens and public health officials, an FDA advisory committee largely endorsed the feasibility of a rapid HIV test that individuals can use in the privacy of their own home. "There's almost unanimous support for this sort of testing," commented Donna DiMichele, acting chairman of the agency's blood products advisory committee, and associate professor of clinical paediatrics at Cornell University Medical School, in New York.